Source: MarketScreener

Acceleron: Acceleron Pharma : Completion of Acquisition or Disposition of Assets - Form 8-K

(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report :November 19, 2021 ...https://www.marketscreener.com/quote/stock/ACCELERON-PHARMA-INC-14297719/news/Acceleron-Pharma-Completion-of-Acquisition-or-Disposition-of-Assets-Form-8-K-37102234/?utm_medium=RSS&utm_content=20211122

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
250-500
Habib Dable's photo - President & CEO of Acceleron

President & CEO

Habib Dable

CEO Approval Rating

93/100

Read more